Researchers find potential target to prevent CRC spread

09/14/2011 | Genetic Engineering & Biotechnology News

Vanderbilt University researchers said a protein called blood vessel epicardial substance may be a potential drug target for preventing the spread of colorectal cancer. They reported in the Journal of Clinical Investigation that BVES is downgraded in colorectal cancer, which leads to cancer spread, but that reintroducing it can stop cells from beginning the metastasis process.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC